Company intelligence / Profile preview

Serenox

Chalgrove, Oxfordshire, United Kingdomserenox.com ↗

Ownership: Private
Development stage: Commercial

Overview

Serenox is developing a suite of rapid, accurate diagnostic tests using advanced sequencing and bioinformatics platforms. Their focus is on enabling early cancer detection, infection surveillance, and non-invasive prenatal diagnosis of hemoglobinopathies in sub-Saharan Africa. The company partners with other biotech firms to deliver cost-effective solutions but has not yet reported clinical trial results or commercial launches.

Therapeutic areas: OncologyInfectious DiseasesHematology
Modalities: DNA sequencing-based diagnosticsLateral flow testingNon-invasive prenatal diagnosis
Industry: Molecular Diagnostics

Partnerships

Partnering with various sequencing providers and biotechnology firms to enable cost-effective diagnostics in Africa

Beyond the preview

Go deeper on Serenox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serenox.

Explore the full profile